title: Immunologic specificity of lymphocyte cell lines from dogs exposed to beryllium oxide.
abstract: We have reported that dogs exposed twice to aerosols of beryllium oxide (BeO) developed Be-specific immune responses within the lung, along with granulomatous and fibrotic lung lesions. To evaluate the specificity of the immune response, lymphocytes from lungs and blood of BeO-exposed dogs were co-cultured over an irradiated blood monocyte layer, alternately with interleukin 2 and BeSO4. Resultant cell lines were then tested for their response to different metal cations, common canine recall antigens, and BeSO4 in an in vitro cell proliferation assay. The cell lines responded to BeSO4 in a dose-dependent fashion, with mean stimulation indices of 7, 58, 119, and 112 at concentrations of 0.01, 1.0, 10, and 100 microM BeSO4 respectively. Cells not proliferate when incubated with ZnSO4 or NiSO4, or with canine distemper, leptospira, adenovirus 2, parvovirus, or parainfluenza antigens. Lymphocytes from normal vaccinated dogs proliferated markedly when cultured with these antigens. Cells from the cultured cell lines (91%) stained with Thy-1 (a pan T-cell marker) and 96% stained with DT2 (a helper T-cell marker). Furthermore, the Be-induced proliferative response was restricted by major histocompatibility (MHC) class II antigens. These data reinforce the premise that inhalation exposure of dogs to BeO produces lung lesions and MHC class II restricted immunologic responses mediated by Be-specific, helper T-Cells. These data further confirm the hypothesis that antigen localized to the lung results in the recruitment of T-cells to the lung, followed by localized antigen-specific, cell-mediated immune responses.
authors.affiliation: Lovelace Respiratory Research Institute, Albuquerque, NM 87185, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Haley
authors.forename: D S
authors.initials: DS
authors.lastname: Swafford
authors.forename: G L
authors.initials: GL
authors.lastname: Finch
authors.forename: M D
authors.initials: MD
authors.lastname: Hoover
authors.forename: B A
authors.initials: BA
authors.lastname: Muggenburg
authors.forename: N F
authors.initials: NF
authors.lastname: Johnson
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001608:Beryllium / Q000494:pharmacology*; D002460:Cell Line; D002478:Cells, Cultured; D004285:Dogs; D005260:Female; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D008168:Lung / Q000166:cytology; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology*; D008297:Male; D008670:Metals / Q000494:pharmacology; D012680:Sensitivity and Specificity
chemical_list: D000336:Aerosols; D000906:Antibodies; D000949:Histocompatibility Antigens Class II; D008670:Metals; C032777:beryllium oxide; D001608:Beryllium